Compound details
4-Hydroxycinnamoylagmatine
| Compound ID | CDAMM02562 |
|---|---|
| Common name | 4-Hydroxycinnamoylagmatine | IUPAC name | N-[4-(diaminomethylideneamino)butyl]-3-(4-hydroxyphenyl)prop-2-enamide |
| Molecular formula | C14H20N4O2 |
| Retention time | 9.54 |
|---|---|
| Adduct | [M+Na]+ |
| Actual mz | 299.147 | Theoretical mz | 299.148 |
| Error | 3.74 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 7.5784 |
| Inchi key | AKIHYQWCLCDMMI-VMPITWQZSA-N |
|---|---|
| Smiles | O=C(C=CC1=CC=C(O)C=C1)NCCCCNC(=N)N |
| Superclass | Phenylpropanoids and polyketides |
| Class | Cinnamic acids and derivatives |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| P00533 | EGFR | Epidermal growth factor receptor erbB1 | T59328 | SwissTargetPrediction |
| P22303 | ACHE | Acetylcholinesterase | T30082 | SwissTargetPrediction |
| O15379 | HDAC3 | Histone deacetylase 3 | T05090 | SEA |
| P00915 | CA1 | Carbonic anhydrase I | T13201 | SwissTargetPrediction |
| P05067 | APP | Beta amyloid A4 protein | T87024 | SEA |
| P14416 | DRD2 | Dopamine D2 receptor | T67162 | SEA |
| P06280 | GLA | Alpha-galactosidase A | T61339 | SEA |
| P43166 | CA7 | Carbonic anhydrase VII | T37541 | SEA |
| P23280 | CA6 | Carbonic anhydrase VI | T06569 | SEA |
| Q9ULX7 | CA14 | Carbonic anhydrase XIV | T31992 | SEA |
| P27338 | MAOB | Monoamine oxidase B | T83011 | SEA |
| P42261 | GRIA1 | Glutamate receptor ionotropic, AMPA 1 | T33584 | SEA |
| P15121 | AKR1B1 | Aldose reductase | T26623 | SEA |
| Q9UQL6 | HDAC5 | Histone deacetylase 5 | T07930 | SEA |
| Q8WUI4 | HDAC7 | Histone deacetylase 7 | T98698 | SEA |
| P56524 | HDAC4 | Histone deacetylase 4 | T63816 | SEA |
| Q9UKV0 | HDAC9 | Histone deacetylase 9 | T03687 | SEA |
| Q92769 | HDAC2 | Histone deacetylase 2 | T51191 | SEA |
| P11926 | ODC1 | Ornithine decarboxylase | T60366 | SEA |
| P51681 | CCR5 | C-C chemokine receptor type 5 | T09960 | SwissTargetPrediction |
| P08253 | MMP2 | Matrix metalloproteinase 2 | T68251 | SEA |
| P14780 | MMP9 | Matrix metalloproteinase 9 | T54156 | SEA |
| P03956 | MMP1 | Matrix metalloproteinase 1 | T52450 | SEA |
| P13726 | F3 | Coagulation factor VII/tissue factor | T72702 | SEA |
| P35462 | DRD3 | Dopamine D3 receptor | T02551 | SEA |
| Q15118 | PDK1 | Pyruvate dehydrogenase kinase isoform 1 | T20891 | SwissTargetPrediction |
| P06276 | BCHE | Butyrylcholinesterase | T99799 | SEA |
| P56817 | BACE1 | Beta-secretase 1 | T79031 | SEA |
| P43116 | PTGER2 | Prostanoid EP2 receptor | T38529 | SEA |
| P13500 | CCL2 | C-C motif chemokine 2 | T89988 | SEA |
| O75116 | ROCK2 | Rho-associated protein kinase 2 | T06093 | SwissTargetPrediction |
| P05362 | ICAM1 | Intercellular adhesion molecule-1 | T26203 | SEA |
| Q9NR96 | TLR9 | Toll-like receptor (TLR7/TLR9) | T11451 | SEA |
| Q6P179 | ERAP2 | Endoplasmic reticulum aminopeptidase 2 | T65818 | SwissTargetPrediction and SEA |
| P06737 | PYGL | Liver glycogen phosphorylase | T19184 | SEA |
| P41146 | OPRL1 | Nociceptin receptor | T52921 | SEA |
| P25929 | NPY1R | Neuropeptide Y receptor type 1 | T89213 | SEA |
| Q13258 | PTGDR | Prostanoid DP receptor | T68782 | SEA |
| P00749 | PLAU | Urokinase-type plasminogen activator | T17758 | SwissTargetPrediction |
| P04049 | RAF1 | Serine/threonine-protein kinase RAF | T51883 | SwissTargetPrediction |
| Q16581 | C3AR1 | C3a anaphylatoxin chemotactic receptor | T30219 | SEA |
| P15056 | BRAF | Serine/threonine-protein kinase B-raf | T99089 | SwissTargetPrediction |
| P03952 | KLKB1 | Plasma kallikrein | T82739 | SwissTargetPrediction |
| P08709 | F7 | Coagulation factor VII | T43332 | SwissTargetPrediction |
| P00374 | DHFR | Dihydrofolate reductase | T17345 | SwissTargetPrediction |
| Q9UIQ6 | LNPEP | Cystinyl aminopeptidase | T97537 | SwissTargetPrediction and SEA |
| P10636 | MAPT | Microtubule-associated protein tau | T45593 | SEA |
| Q04760 | GLO1 | Glyoxalase I | T88285 | SEA |
| P61964 | WDR5 | WD repeat-containing protein 5 | T77393 | SEA |
| P61073 | CXCR4 | C-X-C chemokine receptor type 4 | T96079 | SEA |
| Q15661 | TPSAB1 | Tryptase beta-1 | T14558 | SEA |
| Q8IU80 | TMPRSS6 | Transmembrane protease serine 6 | T13863 | SEA |
| Q16236 | NFE2L2 | Nuclear factor erythroid 2-related factor 2 | T88505 | SEA |
| Q96DB2 | HDAC11 | Histone deacetylase 11 | T97903 | SEA |
| P33032 | MC5R | Melanocortin receptor 5 | T95302 | SEA |
| Q9H7B4 | SMYD3 | Histone-lysine N-methyltransferase SMYD3 | T35792 | SwissTargetPrediction |
| O94759 | TRPM2 | Transient receptor potential cation channel subfamily M member 2 | T78205 | SEA |
| Q969S8 | HDAC10 | Histone deacetylase 10 | T94324 | SEA |
| Q9Y345 | SLC6A5 | Glycine transporter 2 | T58937 | SEA |
| Q04756 | HGFAC | Hepatocyte growth factor activator | T38584 | SwissTargetPrediction |
| P13501 | CCL5 | C-C motif chemokine 5 | T16263 | SwissTargetPrediction |
| P09668 | CTSH | Cathepsin (H and K) | T40103 | SEA |
| P09958 | FUR | HUMAN dibasic-processing enzyme | T98945 | SEA |
| P29120 | PCSK1 | Neuroendocrine convertase 1 | T36445 | SEA |
| Q92824 | PCSK5 | Proprotein convertase subtilisin/kexin type 5 | T38581 | SEA |
| Q9GZQ6 | NPFFR1 | Neuropeptide FF receptor 1 | T79780 | SEA |
| Q9Y5X5 | NPFFR2 | Neuropeptide FF receptor 2 | T90818 | SEA |
| O60259 | KLK8 | Neuropsin | T43289 | SEA |
| Q9BY41 | HDAC8 | Histone deacetylase 8 | T28887 | SEA |
| Q9Y5K2 | KLK4 | Kallikrein-4 | T79400 | SEA |
| P37088 | SCNN1A | Amiloride-sensitive sodium channel | T52173 | SEA |
| Q9Y4G9 | PCSK6 | Proprotein convertase subtilisin/kexin type 6 | T86503 | SEA |
| P42263 | GRIA3 | Glutamate receptor AMPA 3 | T62391 | SEA |
| P01100 | FOS | Proto-oncogene c-Fos | T28025 | SEA |
| Q9UHJ5 | PRLR | Prolactin receptor | T26226 | SEA |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T59328 | DI0030 | Angina pectoris | [ICD-11: BA40] | P00533 | EGFR |
| T59328 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P00533 | EGFR |
| T59328 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | P00533 | EGFR |
| T59328 | DI0121 | Diabetic foot ulcer | [ICD-11: BD54] | P00533 | EGFR |
| T59328 | DI0220 | Ischemia | [ICD-11: 8B10-8B11] | P00533 | EGFR |
| T59328 | DI0238 | Lung cancer | [ICD-11: 2C25] | P00533 | EGFR |
| T59328 | DI0303 | Non-small-cell lung cancer | [ICD-11: 2C25] | P00533 | EGFR |
| T59328 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P00533 | EGFR |
| T59328 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P00533 | EGFR |
| T59328 | DI0420 | Unspecific body region injury | [ICD-11: ND56] | P00533 | EGFR |
| T30082 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P22303 | ACHE |
| T30082 | DI0166 | Glaucoma | [ICD-11: 9C61] | P22303 | ACHE |
| T30082 | DI0282 | Myasthenia gravis | [ICD-11: 8C6Y] | P22303 | ACHE |
| T30082 | DI0313 | Oesophageal/gastroduodenal disorder | [ICD-11: DD90] | P22303 | ACHE |
| T30082 | DI0332 | Pediculosis | [ICD-11: 1G00] | P22303 | ACHE |
| T30082 | DI0421 | Unspecific substance harmful effect | [ICD-11: NE6Z] | P22303 | ACHE |
| T05090 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | O15379 | HDAC3 |
| T05090 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | O15379 | HDAC3 |
| T13201 | DI0166 | Glaucoma | [ICD-11: 9C61] | P00915 | CA1 |
| T13201 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | P00915 | CA1 |
| T87024 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P05067 | APP |
| T87024 | DI0122 | Diagnostic imaging | [ICD-11: N.A.] | P05067 | APP |
| T67162 | DI0022 | Allergic/hypersensitivity disorder | [ICD-11: 4A80-4A8Z] | P14416 | DRD2 |
| T67162 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P14416 | DRD2 |
| T67162 | DI0037 | Asthma | [ICD-11: CA23] | P14416 | DRD2 |
| T67162 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | P14416 | DRD2 |
| T67162 | DI0051 | Bipolar disorder | [ICD-11: 6A60] | P14416 | DRD2 |
| T67162 | DI0063 | Breathing abnormality | [ICD-11: MD11] | P14416 | DRD2 |
| T67162 | DI0070 | Cardiovascular disease | [ICD-11: BA00-BE2Z] | P14416 | DRD2 |
| T67162 | DI0073 | Cerebral ischaemia | [ICD-11: 8B1Z] | P14416 | DRD2 |
| T67162 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P14416 | DRD2 |
| T67162 | DI0124 | Digestive system disease | [ICD-11: DE2Z] | P14416 | DRD2 |
| T67162 | DI0137 | Essential hypertension | [ICD-11: BA00] | P14416 | DRD2 |
| T67162 | DI0142 | Faecal incontinence | [ICD-11: ME07] | P14416 | DRD2 |
| T67162 | DI0156 | Gangrene | [ICD-11: MC85] | P14416 | DRD2 |
| T67162 | DI0166 | Glaucoma | [ICD-11: 9C61] | P14416 | DRD2 |
| T67162 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P14416 | DRD2 |
| T67162 | DI0185 | Hyperaemia | [ICD-11: 9A61-9B7Y] | P14416 | DRD2 |
| T67162 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P14416 | DRD2 |
| T67162 | DI0196 | Hypotension | [ICD-11: BA20-BA21] | P14416 | DRD2 |
| T67162 | DI0205 | Inborn porphyrin/heme metabolism error | [ICD-11: 5C58] | P14416 | DRD2 |
| T67162 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P14416 | DRD2 |
| T67162 | DI0222 | Itching | [ICD-11: 1F28-1G07] | P14416 | DRD2 |
| T67162 | DI0264 | Migraine | [ICD-11: 8A80] | P14416 | DRD2 |
| T67162 | DI0293 | Nausea/vomiting | [ICD-11: MD90] | P14416 | DRD2 |
| T67162 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P14416 | DRD2 |
| T67162 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P14416 | DRD2 |
| T67162 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | P14416 | DRD2 |
| T67162 | DI0340 | Postpartum haemorrhage | [ICD-11: JA43] | P14416 | DRD2 |
| T67162 | DI0354 | Psychotic disorder | [ICD-11: 6A20-6A25] | P14416 | DRD2 |
| T67162 | DI0356 | Pulmonary hypertension | [ICD-11: BB01] | P14416 | DRD2 |
| T67162 | DI0370 | Schizophrenia | [ICD-11: 6A20] | P14416 | DRD2 |
| T67162 | DI0396 | Substance abuse | [ICD-11: 6C40] | P14416 | DRD2 |
| T67162 | DI0408 | Thyrotoxicosis | [ICD-11: 5A02] | P14416 | DRD2 |
| T67162 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P14416 | DRD2 |
| T61339 | DI0201 | Inborn carbohydrate metabolism error | [ICD-11: 5C51] | P06280 | GLA |
| T06569 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | P23280 | CA6 |
| T06569 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | P23280 | CA6 |
| T31992 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | Q9ULX7 | CA14 |
| T31992 | DI0204 | Inborn metabolism deficiency | [ICD-11: 5C50-5C59] | Q9ULX7 | CA14 |
| T83011 | DI0115 | Dementia | [ICD-11: 6D80-6D8Z] | P27338 | MAOB |
| T83011 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P27338 | MAOB |
| T83011 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P27338 | MAOB |
| T83011 | DI0243 | Malaria | [ICD-11: 1F40-1F45] | P27338 | MAOB |
| T83011 | DI0264 | Migraine | [ICD-11: 8A80] | P27338 | MAOB |
| T83011 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P27338 | MAOB |
| T33584 | DI0298 | Neuropathy | [ICD-11: 8C0Z] | P42261 | GRIA1 |
| T26623 | DI0298 | Neuropathy | [ICD-11: 8C0Z] | P15121 | AKR1B1 |
| T26623 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P15121 | AKR1B1 |
| T63816 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P56524 | HDAC4 |
| T51191 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | Q92769 | HDAC2 |
| T51191 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q92769 | HDAC2 |
| T60366 | DI0020 | African trypanosomiasis | [ICD-11: 1F51] | P11926 | ODC1 |
| T09960 | DI0184 | Human immunodeficiency virus disease | [ICD-11: 1C60-1C62] | P51681 | CCR5 |
| T68251 | DI0238 | Lung cancer | [ICD-11: 2C25] | P08253 | MMP2 |
| T54156 | DI0219 | Ischaemic/haemorrhagic stroke | [ICD-11: 8B20] | P14780 | MMP9 |
| T54156 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P14780 | MMP9 |
| T54156 | DI0395 | Stomach cancer | [ICD-11: 2B72] | P14780 | MMP9 |
| T54156 | DI0419 | Ulcerative colitis | [ICD-11: DD71] | P14780 | MMP9 |
| T52450 | DI0238 | Lung cancer | [ICD-11: 2C25] | P03956 | MMP1 |
| T72702 | DI0075 | Cervical cancer | [ICD-11: 2C77] | P13726 | F3 |
| T02551 | DI0051 | Bipolar disorder | [ICD-11: 6A60] | P35462 | DRD3 |
| T02551 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P35462 | DRD3 |
| T20891 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | Q15118 | PDK1 |
| T99799 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P06276 | BCHE |
| T99799 | DI0411 | Tonus and reflex abnormality | [ICD-11: MB47] | P06276 | BCHE |
| T79031 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P56817 | BACE1 |
| T38529 | DI0003 | Abortion | [ICD-11: JA00] | P43116 | PTGER2 |
| T38529 | DI0102 | Coronary atherosclerosis | [ICD-11: BA52] | P43116 | PTGER2 |
| T38529 | DI0121 | Diabetic foot ulcer | [ICD-11: BD54] | P43116 | PTGER2 |
| T38529 | DI0166 | Glaucoma | [ICD-11: 9C61] | P43116 | PTGER2 |
| T38529 | DI0356 | Pulmonary hypertension | [ICD-11: BB01] | P43116 | PTGER2 |
| T38529 | DI0378 | Sexual dysfunction | [ICD-11: HA00-HA01] | P43116 | PTGER2 |
| T38529 | DI0413 | Transplant rejection | [ICD-11: NE84] | P43116 | PTGER2 |
| T89988 | DI0083 | Chronic kidney disease | [ICD-11: GB61] | P13500 | CCL2 |
| T89988 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P13500 | CCL2 |
| T89988 | DI0087 | Chronic pain | [ICD-11: MG30] | P13500 | CCL2 |
| T89988 | DI0184 | Human immunodeficiency virus disease | [ICD-11: 1C60-1C62] | P13500 | CCL2 |
| T89988 | DI0252 | Melanoma | [ICD-11: 2C30] | P13500 | CCL2 |
| T89988 | DI0262 | Metastatic tumour | [ICD-11: 2D50-2E2Z] | P13500 | CCL2 |
| T89988 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | P13500 | CCL2 |
| T89988 | DI0326 | Pancreatic cancer | [ICD-11: 2C10] | P13500 | CCL2 |
| T89988 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P13500 | CCL2 |
| T89988 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P13500 | CCL2 |
| T06093 | DI0168 | Graft-versus-host disease | [ICD-11: 4B24] | O75116 | ROCK2 |
| T26203 | DI0436 | Visual system disease | [ICD-11: 9E1Z] | P05362 | ICAM1 |
| T11451 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | Q9NR96 | TLR9 |
| T11451 | DI0179 | Hepatitis virus infection | [ICD-11: 1E50-1E51] | Q9NR96 | TLR9 |
| T11451 | DI0252 | Melanoma | [ICD-11: 2C30] | Q9NR96 | TLR9 |
| T11451 | DI0346 | Prostate cancer | [ICD-11: 2C82] | Q9NR96 | TLR9 |
| T52921 | DI0039 | Atopic eczema | [ICD-11: EA80] | P41146 | OPRL1 |
| T52921 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P41146 | OPRL1 |
| T52921 | DI0173 | Headache | [ICD-11: 8A80-8A84] | P41146 | OPRL1 |
| T52921 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P41146 | OPRL1 |
| T89213 | DI0050 | Binge eating disorder | [ICD-11: 6B82] | P25929 | NPY1R |
| T89213 | DI0070 | Cardiovascular disease | [ICD-11: BA00-BE2Z] | P25929 | NPY1R |
| T89213 | DI0174 | Heart disease | [ICD-11: BA41-BA42] | P25929 | NPY1R |
| T89213 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P25929 | NPY1R |
| T89213 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P25929 | NPY1R |
| T68782 | DI0102 | Coronary atherosclerosis | [ICD-11: BA52] | Q13258 | PTGDR |
| T17758 | DI0211 | Inherited coagulation factor deficiency | [ICD-11: 3B14] | P00749 | PLAU |
| T17758 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | P00749 | PLAU |
| T51883 | DI0252 | Melanoma | [ICD-11: 2C30] | P04049 | RAF1 |
| T51883 | DI0303 | Non-small-cell lung cancer | [ICD-11: 2C25] | P04049 | RAF1 |
| T51883 | DI0321 | Ovarian cancer | [ICD-11: 2C73] | P04049 | RAF1 |
| T51883 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P04049 | RAF1 |
| T99089 | DI0252 | Melanoma | [ICD-11: 2C30] | P15056 | BRAF |
| T82739 | DI0213 | Innate/adaptive immunodeficiency | [ICD-11: 4A00] | P03952 | KLKB1 |
| T82739 | DI0364 | Retinal vascular occlusion | [ICD-11: 9B74] | P03952 | KLKB1 |
| T43332 | DI0091 | Coagulation defect | [ICD-11: 3B10] | P08709 | F7 |
| T17345 | DI0207 | Indeterminate colitis | [ICD-11: DD72] | P00374 | DHFR |
| T17345 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P00374 | DHFR |
| T17345 | DI0416 | Tuberculosis | [ICD-11: 1B10-1B12] | P00374 | DHFR |
| T17345 | DI0427 | Urinary tract infection | [ICD-11: GC08] | P00374 | DHFR |
| T45593 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P10636 | MAPT |
| T45593 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P10636 | MAPT |
| T45593 | DI0265 | Mild neurocognitive disorder | [ICD-11: 6D71] | P10636 | MAPT |
| T88285 | DI0210 | Influenza | [ICD-11: 1E30-1E32] | Q04760 | GLO1 |
| T96079 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P61073 | CXCR4 |
| T96079 | DI0274 | Multiple myeloma | [ICD-11: 2A83] | P61073 | CXCR4 |
| T14558 | DI0155 | Fungal infection | [ICD-11: 1F29-1F2F] | Q15661 | TPSAB1 |
| T14558 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q15661 | TPSAB1 |
| T88505 | DI0038 | Ataxic disorder | [ICD-11: 8A03] | Q16236 | NFE2L2 |
| T95302 | DI0005 | Acne vulgaris | [ICD-11: ED80] | P33032 | MC5R |
| T95302 | DI0371 | Sebaceous gland disorder | [ICD-11: ED91] | P33032 | MC5R |
| T35792 | DI0094 | Colon cancer | [ICD-11: 2B90] | Q9H7B4 | SMYD3 |
| T35792 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9H7B4 | SMYD3 |
| T94324 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q969S8 | HDAC10 |
| T16263 | DI0120 | Diabetes mellitus | [ICD-11: 5A10] | P13501 | CCL5 |
| T98945 | DI0263 | Middle East Respiratory Syndrome | [ICD-11: 1D64] | P09958 | FUR |
| T28887 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9BY41 | HDAC8 |
| T52173 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P37088 | SCNN1A |
| T52173 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P37088 | SCNN1A |
| T52173 | DI0311 | Oedema | [ICD-11: MG29] | P37088 | SCNN1A |
| T62391 | DI0298 | Neuropathy | [ICD-11: 8C0Z] | P42263 | GRIA3 |
| T26226 | DI0143 | Fallopian tube cancer | [ICD-11: 2C74] | Q9UHJ5 | PRLR |
| T26226 | DI0321 | Ovarian cancer | [ICD-11: 2C73] | Q9UHJ5 | PRLR |
| T26226 | DI0334 | Peritoneal cancer | [ICD-11: 2C51] | Q9UHJ5 | PRLR |
| T26226 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9UHJ5 | PRLR |